London, England, United Kingdom In 2000 was created Inventages Venture Capital Investment Inc., which is appeared as VC. The fund was located in Europe if to be more exact in United Kingdom. The main department of described VC is located in the London.
This organization was formed by Gunnar Weikert. The overall number of key employees were 2.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Inventages Venture Capital Investment Inc., startups are often financed by POSCO BioVentures, Seroba Life Sciences, Idinvest Partners. The meaningful sponsors for the fund in investment in the same round are Seroba Life Sciences, POSCO BioVentures, Enterprise Ireland. In the next rounds fund is usually obtained by BB Biotech Ventures, Ysios Capital, Roche Venture Fund.
Among the most successful fund investment fields, there are Manufacturing, Health Care. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight AM Pharma, MSI Methylation Sciences, Opsona. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups.
Speaking about the real fund results, this VC is 40 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Inventages Venture Capital Investment Inc. performs on 23 percentage points less the average number of lead investments. The higher amount of exits for fund were in 2016. The top activity for fund was in 2007. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in 2-6 deals every year.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Austin Impact Capital | Austin, Texas, United States |
| Banco Bradesco | Brazil, Osasco, São Paulo |
| Berkeley Angel Network | California, San Francisco, United States |
| Bit-isle, Inc. | Japan, Tokyo |
| Blue Star Capital | England, London, United Kingdom |
| CLP Holdings | China, Hong Kong, Kowloon |
| Fox Ventures | Beltsville, Maryland, United States |
| Hanley Wood | District of Columbia, United States, Washington |
| Hedera Finances | France, Ile-de-France, Versailles |
| Jingyuewenhua | - |
| Jisi Capital | - |
| Mizuho Corporate Bank | Chiyoda, Japan |
| Phillip Capital Management | - |
| Porte Monnaie | - |
| SINE | Assam, India, Powai |
| SOJE Capital | - |
| Startup Braga | Braga, North, Portugal |
| Tanarra Credit Partners | Australia, Melbourne, Victoria |
| Techstars Impact Accelerator | Austin, Texas, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Phagenesis | $17M | 22 May 2013 | England | ||
Phagenesis | $8M | 04 Oct 2011 | England | ||
MSI Methylation Sciences | $15M | 29 Sep 2011 | Burnaby, British Columbia, Canada | ||
Shield Therapeutics | $9M | 01 Jun 2011 | England | ||
MooBella | $18M | 18 Sep 2009 | Taunton, Massachusetts, United States | ||
Opsona | $4M | 16 Jun 2009 | County Dublin | ||
Opsona | $21M | 19 Feb 2009 | Dublin, County Dublin, Ireland | ||
Accera | $35M | 12 Nov 2008 | Broomfield, Colorado, United States | ||
Cognoptix | $18M | 22 Oct 2008 | Marlborough, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Phagenesis | $17M | 22 May 2013 | England | ||
Phagenesis | $8M | 04 Oct 2011 | England | ||
MSI Methylation Sciences | $15M | 29 Sep 2011 | Burnaby, British Columbia, Canada | ||
Shield Therapeutics | $9M | 01 Jun 2011 | England | ||
MooBella | $18M | 18 Sep 2009 | Taunton, Massachusetts, United States | ||
Opsona | $4M | 16 Jun 2009 | County Dublin | ||
Opsona | $21M | 19 Feb 2009 | Dublin, County Dublin, Ireland | ||
Accera | $35M | 12 Nov 2008 | Broomfield, Colorado, United States | ||
Cognoptix | $18M | 22 Oct 2008 | Marlborough, Massachusetts, United States |
